MOESM4 of TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis

Stephanie Williams (Creator)
Galam Khan (Contributor)
Brent T. Harris (Creator)
John M. Ravits (Creator)
Michael Sierks (Creator)

Dataset

Description

Additional file 4: Figure S4. Analysis of Purified Soluble Antibody Fragments by Western Blot. Following Niâ NTA purification of 17 of the 23 scFvs, analysis by Western blotting indicated the presence of the expected ~28Â kDa band corresponding to a full length scFv (except for ALS-TDP10). The estimated molecular weight for each scFv is indicated below their respective band.

Date made available	2017
Publisher	figshare Academic Research System

DOI
10.6084/m9.figshare.c.3674713_d2.v1

Access Dataset

CC BY + CC0

1 Article

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
Williams, S. M., Khan, G., Harris, B. T., Ravits, J. & Sierks, M., Jan 25 2017, In: BMC Neuroscience. 18, 1, 20.
Research output: Contribution to journal › Article › peer-review

Open Access
24 Scopus citations

MOESM4 of TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis

Description

DOI

Access Dataset

Research output

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis

Cite this